Micrographic Surgery and Dermatologic Oncology Fellowship Selection Criteria.

Dermatol Surg

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.

Published: March 2019

Background: Obtaining a fellowship position for Micrographic Surgery and Dermatologic Oncology (MSDO) is becoming very competitive. Applicant qualities desired by MSDO fellowship directors have not been previously explored in a systematic way.

Objective: To characterize the prevailing practices of selecting MSDO fellows.

Methods And Materials: Cross-sectional study based on an anonymous online survey of MSDO fellowship directors.

Results: There were 34 completed surveys. Selection criteria with the highest importance to fellowship directors were the ability to work well and get along with others, interview, work ethic, and letter of recommendation from the Mohs micrographic surgery director at the applicant's residency. The criteria with the lowest importance were advanced degrees, medical licensing examination scores, and membership in Alpha Omega Alpha. Specific applicant factors that were looked upon most positively by fellowship directors include applicant from own institution and applicant's personal reasons and circumstances, whereas factors that were most unfavorable include applicant's desire to practice in the same city/area as the fellowship location and graduate of foreign medical school.

Conclusion: Although variations existed, MSDO fellowship directors collectively placed greater importance on criteria that reflect interpersonal skills than on objective measures of academic performance, which highlights the importance of "fit."

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000001677DOI Listing

Publication Analysis

Top Keywords

fellowship directors
16
micrographic surgery
12
msdo fellowship
12
surgery dermatologic
8
dermatologic oncology
8
fellowship
8
selection criteria
8
msdo
5
oncology fellowship
4
fellowship selection
4

Similar Publications

Study Objective: A desire for curriculum standardization in obstetrics and gynecology residencies has been identified. No prior investigation of educational experiences in Fellowship in Minimally Invasive Gynecologic Surgery (FMIGS) programs has been completed. The purpose of this study was to determine the state of FMIGS didactic education and the perceptions that fellowship directors and fellows have regarding a standardized curriculum.

View Article and Find Full Text PDF

Hearing Loss and Discrimination: Evidence of Intersectionality in the All of Us Research Program.

Laryngoscope

January 2025

Department of Otolaryngology-Head and Neck Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, Columbia University Vagelos College of Physicians and Surgeons, 180 Fort Washington Avenue, HP8, New York, New York, 10032, U.S.A.

Objectives: Hearing loss (HL) has significant implications on social functioning. Here, we study the relationship between HL, race, and these combined categories as risk factors for discrimination in the large national All of Us cohort.

Methods: The National Institutes of Health All of Us dataset was analyzed after including individuals who completed the Everyday Discrimination Survey between November 2021 and January 2022.

View Article and Find Full Text PDF

Background: Women continue to make up a minority of orthopedic surgeons, especially shoulder and elbow surgeons. There exists no study that investigates the effect of gender on one's academic career as a shoulder and elbow orthopedic surgeon, which was the purpose of this cross-sectional study.

Methods: The American Shoulder and Elbow Surgeons website was used to identify surgeons.

View Article and Find Full Text PDF

Future directions in the evaluation and management of newly diagnosed metastatic cancer.

Crit Rev Oncol Hematol

January 2025

Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address:

There is a much debate regarding optimal selection in patients with metastatic cancer who should undergo local treatment (surgery or radiation treatment) to the primary tumor and/or metastases. Additionally, the optimal treatment of newly diagnosed metastatic cancer is largely unclear. Current prognostication systems to best inform these clinical scenarios are limited, as all metastatic patients are grouped together as having Stage IV disease without further incorporation of patient and disease-specific covariates that significantly impact patient outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!